Experimental Mesothelioma Drugs and the New Right-to-Try Law

Legislation signed this week by President Trump could pave the way for mesothelioma patients to access promising experimental treatments—even years before they are approved by the FDA. But not everyone thinks it is a good idea. The “Right to Try” legislation gives patients with terminal illnesses like malignant mesothelioma the right to receive new treatments they would not normally be able to get because they haven’t gone through the FDA’s three-phase testing requirement. Controversy Over New Legislation Although the legislation could make it easier for some patients to access potentially life-saving mesothelioma treatments, it is also not without controversy. Some argue it could even be dangerous. Typically, the FDA requires that all proposed mesothelioma therapies go through three-phases of studies … Continue reading Experimental Mesothelioma Drugs and the New Right-to-Try Law »

A Bright Future for Immune Checkpoint Inhibitors in Mesothelioma Treatment

A Bright Future for Immune Checkpoint Inhibitors in Mesothelioma Treatment

A new report shows that immune checkpoint inhibitors can be a practical and rational therapeutic approach to treating mesothelioma patients. The use of ICIs to treat human tumors has quickly become part of clinical practice. Immune checkpoint inhibitors block mesothelioma’s natural resistance to immune system attack. They are among the most promising approaches to combating this intractable cancer. Researchers from the Cellular and Molecular Research Center report the use of ICIs in tumor immunotherapy. What is Tumor Immunotherapy? Malignant mesothelioma is a frustrating disease for patients and doctors. Conventional cancer treatments often do not work. If cancer recurs, doctors can try other approved treatments, even if they are not part of the official treatment guidelines. Immunotherapy is also referred to … Continue reading A Bright Future for Immune Checkpoint Inhibitors in Mesothelioma Treatment »

Targeted Radiotherapy for Mesothelioma May Extend Survival in the Right Patients

targeted radiotherapy for mesothelioma

A meta-analysis conducted by some of the country’s top cancer researchers says targeted radiotherapy for mesothelioma can help some people live longer. It is the first such analysis of targeted radiation after lung-sparing mesothelioma surgery. The team focused on intensity modulated radiation therapy (IMRT). IMRT is more precise than earlier forms of radiation treatment.  The new article appears in Practical Radiation Oncology. It is a meta-analysis of ten smaller studies. The researchers conclude that healthier surgery patients could safely consider targeted radiotherapy for mesothelioma. Making Radiotherapy Less Toxic In the past, radiation for mesothelioma has sometimes done more harm than good. Earlier types of radiation treatment were not as precise as IMRT. When radiation spills over into healthy tissue, it … Continue reading Targeted Radiotherapy for Mesothelioma May Extend Survival in the Right Patients »

Mesothelioma Registry Could Improve Outcomes, Prevent Future Cases

mesothelioma registry

A distinguished team of scientists are calling for a national mesothelioma registry they say could improve outcomes. If the registry collects and provides the right information, they say it could even help prevent future mesothelioma cases. Experts from the CDC, the National Institute for Occupational Safety and Health (NIOSH), and several top US cancer centers participated in a workshop on the topic. The Mesothelioma Applied Research Foundation convened the workshop. The group says existing tumor registries at some cancer centers are not as useful as a national mesothelioma registry. But coordinating a national registry will require government support. What is a Mesothelioma Registry? Malignant mesothelioma is a rare cancer which makes it hard to study. A national mesothelioma registry is … Continue reading Mesothelioma Registry Could Improve Outcomes, Prevent Future Cases »

Australian Registry Releases First Mesothelioma Report

The first report using data from the newly-established Australian Mesothelioma Registry has been released, and the new is not good – especially for the country’s blue collar workers. According to the report from Safe Work Australia, a health and safety advocacy group for the country’s building industry, the Australian Mesothelioma Registry recorded 612 new cases of mesotheliomain 2011. The new national registry became operational in 2011 with a goal of recording and tracking all new mesothelioma cases. The purpose of the registry is to help spot trends, provide research data, etc. Six hundred and twelve new cases in 2011 equates to a rate of 2.7 mesothelioma cases per 100,000 people. However, Safe Work Australia cautions that the number is likely to … Continue reading Australian Registry Releases First Mesothelioma Report »

Mesothelioma Lawsuits Continue Throughout Country

A Texas man who spent his career painting buildings was awarded $11 million after he claimed to have developed mesothelioma from asbestos-containing painting products.  Vernon Walker, 67, of Dallas spent years working daily with contaminated products such as texturing paints, block fillers and drywall compounds, some of which were banned by the Consumer Products Safety Commission in the 1970’s because of their asbestos.  Forty percent of the $11 settlement is to come from asbestos mining company Union Carbide and the rest from various paint product manufacturers. Union Carbide took another recent hit in court from a former employee, who won his $3 million suit against the company and two others he blamed for his mesothelioma.  Oscar Torres’ suit alleged that workers at … Continue reading Mesothelioma Lawsuits Continue Throughout Country »

HIPEC & Mesothelioma: What It Is And What To Expect

HIPEC and mesothelioma

You might have heard the news… Most mesothelioma patients can expect to live for about a year and half… or less. Four to 18 months. That’s it. But with the latest advances in a treatment called HIPEC, patients are now surviving TWICE as long. … and sometimes even longer.  According to a study published in 2019 in the Journal of Surgical Oncology, the average survival rate with HIPEC is now 35 months… that’s almost 3 years! But what exactly is HIPEC? What can you expect? And are there any “secrets” to making HIPEC work even better? There are so many questions that need answering. Like… It can get really overwhelming… and fast. But don’t worry. You’re in good hands…  We … Continue reading HIPEC & Mesothelioma: What It Is And What To Expect »

Get your free copy of
“Surviving Mesothelioma” Today!